QR Code

Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis

<p>Introduction: Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, reduced the risk of heart and kidney outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in FIDELITY, a prespecified pooled analysis of the FIDELIO-DKD and FIGARO-DKD trials. Th...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Ping Li, Yu An, Hongguang Zheng, Weiping Lu, Zhaohui Mo, Xudong Xu, Yibing Lu, Chaoqing Wu, Jingyuan Xie, Nanwei Tong, Fang Liu, Qinkai Chen, Jingjing Tang, Meike Brinker, Luke Roberts, Dalong Zhu, Zhihong Liu
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Karger Publishers 2026-01-01
Rangatū:Kidney Diseases
Urunga tuihono:https://karger.com/article/doi/10.1159/000550850
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite